Life Sciences Group Of The Year: Latham
Latham & Watkins LLP was rewarded for taking a biotech company's securities class action to trial and backed the U.S. Food and Drug Administration as it enforced restrictions on compounding drugs,...To view the full article, register now.
Already a subscriber? Click here to view full article